Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$548.35 - $738.84 $893,810 - $1.2 Million
-1,630 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$595.12 - $698.43 $23,209 - $27,238
-39 Reduced 2.34%
1,630 $1.14 Million
Q4 2021

Jan 19, 2022

SELL
$543.48 - $670.97 $630,980 - $778,996
-1,161 Reduced 41.02%
1,669 $1.05 Million
Q3 2021

Oct 05, 2021

BUY
$574.03 - $680.96 $4,592 - $5,447
8 Added 0.28%
2,830 $1.71 Million
Q2 2021

Jul 12, 2021

SELL
$472.8 - $558.54 $222,688 - $263,072
-471 Reduced 14.3%
2,822 $1.58 Million
Q1 2021

Apr 22, 2021

SELL
$446.73 - $548.2 $133,125 - $163,363
-298 Reduced 8.3%
3,293 $1.56 Million
Q4 2020

Jan 25, 2021

BUY
$478.3 - $607.98 $106,182 - $134,971
222 Added 6.59%
3,591 $1.74 Million
Q3 2020

Oct 16, 2020

BUY
$544.75 - $658.21 $481,014 - $581,199
883 Added 35.52%
3,369 $1.89 Million
Q2 2020

Jul 08, 2020

BUY
$493.32 - $643.92 $162,302 - $211,849
329 Added 15.25%
2,486 $1.55 Million
Q1 2020

Apr 07, 2020

BUY
$336.18 - $494.43 $244,402 - $359,450
727 Added 50.84%
2,157 $1.05 Million
Q4 2019

Jan 07, 2020

SELL
$274.13 - $376.51 $12,884 - $17,695
-47 Reduced 3.18%
1,430 $537,000
Q3 2019

Nov 06, 2019

SELL
$273.46 - $318.39 $4,101 - $4,775
-15 Reduced 1.01%
1,477 $410,000
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $9,287 - $12,859
31 Added 2.12%
1,492 $467,000
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $15,627 - $18,461
42 Added 2.96%
1,461 $600,000
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $36,268 - $43,528
-108 Reduced 7.07%
1,419 $530,000
Q3 2018

Nov 07, 2018

SELL
$351.14 - $408.51 $78,655 - $91,506
-224 Reduced 12.79%
1,527 $617,000
Q2 2018

Aug 13, 2018

SELL
$284.6 - $344.99 $61,473 - $74,517
-216 Reduced 10.98%
1,751 $604,000
Q1 2018

May 10, 2018

SELL
$315.82 - $393.78 $7,895 - $9,844
-25 Reduced 1.26%
1,967 $677,000
Q4 2017

Feb 07, 2018

BUY
$358.63 - $469.95 $8,607 - $11,278
24 Added 1.22%
1,992 $822,000
Q3 2017

Nov 07, 2017

BUY
$431.38 - $504.0 $848,955 - $991,872
1,968
1,968 $969,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.